MedTrace Logo

Diffusion Weighted Magnetic Resonance Imaging and the Optic Nerve Neuropathy.

NCT05353413 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2022-04-29

No results posted yet for this study

Summary

The aim of the project is to create a new, non-invasive and safe protocol for the early diagnosis of various types of optic neuropathies with the use of diffusion magnetic resonance imaging

Conditions

  • Ischemic Optic Neuropathy
  • Optic Neuritis
  • Compressive Optic Neuropathy
  • Traumatic Optic Neuropathy
  • Toxic Optic Neuropathy
  • Hereditary Optic Neuropathies

Interventions

DEVICE

Neuroimaging

Magnetic resonance diffusion tensor imaging of the brain

DIAGNOSTIC_TEST

VEP - visual evoked potential

Electrophysiology of the visual pathway.

DIAGNOSTIC_TEST

Ophthalmology examination.

Full ophthalmological examination (visual acuity, color vision, measurement of intraocular pressure, evaluation of the anterior chamber and the fundus of the eye using a slit lamp and the Volk lens, optical coherence tomography examination of the macula and optic nerve disc (OCT), neurological field vision)

Sponsors & Collaborators

  • University of Bialystok

    collaborator OTHER_GOV

  • Medical University of Bialystok

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-01-01
Primary Completion
2024-01-01
Completion
2024-01-01

Countries

  • Poland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05353413 on ClinicalTrials.gov